Minzasolmin
CAS No. 1802518-92-8
Minzasolmin( —— )
Catalog No. M35629 CAS No. 1802518-92-8
Minzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 424 | Get Quote |
|
| 5MG | 644 | Get Quote |
|
| 10MG | 1036 | Get Quote |
|
| 25MG | 1822 | Get Quote |
|
| 50MG | 3064 | Get Quote |
|
| 100MG | 4797 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMinzasolmin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMinzasolmin(DLX-313) is an alpha-synuclein misfolding inhibitor for the study of Parkinson's disease.
-
DescriptionMinzasolmin is an alpha-synuclein oligomerization inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1802518-92-8
-
Formula Weight425.59
-
Molecular FormulaC23H31N5OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC([C@H](NC(=O)C=1SC(=NC1)N2CCN(C)CC2)CCCC)C=3C=4C(NC3)=CC=CC4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
N'-Methylnicotinamid...
N-methylnicotinamide is a metabolite of niacin (or nicotinamide) and is commonly found in human urine. However low levels of urinary excretion of N-methylnicotinamide indicates niacin deficiency. In patients with liver cirrhosis nicotinamide methylation is increased leading to a rise in urinary N-methylnicotinamide. N-methylnicotinamide has been found to be a microbial metabolite.
-
GLP-1(7-36)
GLP-1 (7-36) amide is a peptide hormone released from intestinal L-cells upon nutrient consumption.
-
Hydroxocobalamin
Hydroxocobalamin (Standard) is the analytical standard of Hydroxocobalamin. This product is intended for research and analytical applications. Hydroxocobalamin (Vitamin B12a) is an injectable naturally occurring form of vitamin B12 with a favorable adverse effect profile, used as a dietary supplement in the treatment of vitamin B12 deficiency including pernicious anemia.
Cart
sales@molnova.com